E
Emily Loter
Researcher at Seattle Children's
Publications - 4
Citations - 206
Emily Loter is an academic researcher from Seattle Children's. The author has contributed to research in topics: Somatic evolution in cancer & Cancer. The author has an hindex of 2, co-authored 4 publications receiving 140 citations.
Papers
More filters
Journal ArticleDOI
Homozygous Mutations in CSF1R Cause a Pediatric-Onset Leukoencephalopathy and Can Result in Congenital Absence of Microglia.
Nynke Oosterhof,Irene J. Chang,Ehsan Ghayoor Karimiani,Laura E. Kuil,Dana M. Jensen,Ray A. M. Daza,Erica Young,Lee Astle,Herma C. van der Linde,Giridhar M. Shivaram,Jeroen Demmers,Caitlin S. Latimer,C. Dirk Keene,Emily Loter,Reza Maroofian,Tjakko J. van Ham,Robert F. Hevner,James T. Bennett +17 more
TL;DR: The results suggest that CSF1R is required for human brain development and establish the csf1rDM fish as a model for microgliopathies and exemplify an under-recognized form of phenotypic expansion.
Journal ArticleDOI
Ultra-Sensitive TP53 Sequencing for Cancer Detection Reveals Progressive Clonal Selection in Normal Tissue over a Century of Human Lifespan.
Jesse J. Salk,Kaitlyn Loubet-Senear,Elisabeth Maritschnegg,Charles C. Valentine,Lindsey N. Williams,Jacob Higgins,Reinhard Horvat,Adriaan Vanderstichele,Daniela Nachmanson,Kathryn T. Baker,Mary J. Emond,Emily Loter,Maria S. Tretiakova,Thierry Soussi,Thierry Soussi,Thierry Soussi,Lawrence A. Loeb,Robert Zeillinger,Paul Speiser,Rosa Ana Risques +19 more
TL;DR: It is shown that low-frequency TP53 mutations exist in multiple healthy tissues and progressively increase in abundance and pathogenicity with older age across tissue types, and great care must be taken to distinguish tumor-derived from age-associated mutations in high-sensitivity clinical cancer diagnostics.
Posted ContentDOI
Ultra-sensitive sequencing for cancer detection reveals progressive clonal selection in normal tissue over a century of human lifespan
Jesse J. Salk,Kaitlyn Loubet-Senear,Elisabeth Maritschnegg,Charles C. Valentine,Lindsey N. Williams,Reinhard Horvat,Adriaan Vanderstichele,Daniela Nachmanson,Kathryn T. Baker,Mary J. Emond,Emily Loter,Thierry Soussi,Lawrence A. Loeb,Robert Zeillinger,Paul Speiser,Rosa Ana Risques +15 more
TL;DR: The results illustrate that subclonal cancer evolutionary processes are a ubiquitous part of normal human aging and great care must be taken to distinguish tumor-derived, from age-associated mutations in high sensitivity clinical cancer diagnostics.
Journal ArticleDOI
Ultra-Sensitive Sequencing for Cancer Detection Reveals Progressive Clonal Selection in Normal Tissue Over a Century of Human Lifespan
Jesse J. Salk,Kaitlyn Loubet-Senear,Elisabeth Maritschnegg,Charles C. Valentine,Lindsey N. Williams,Reinhard Horvat,Adriaan Vanderstichele,Daniela Nachmanson,Kathryn T. Baker,Mary J. Emond,Emily Loter,Thierry Soussi,Lawrence A. Loeb,Robert Zeillinger,Paul Speiser,Rosa Ana Risques +15 more
TL;DR: In this article, the authors demonstrate 80% sensitivity for ovarian cancer detection using ultra-accurate Duplex Sequencing to identify TP53 mutations in uterine lavage from women with and without cancer, and show that low frequency TP53 mutants exist in multiple healthy tissues, from newborn to centenarian, and progressively increase in abundance and pathogenicity with older age across tissue types.